Cutler Group LP Rigel Pharmaceuticals Inc Put Options Transaction History

Cutler Group LP

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 Apr 14, 2022	SELL	$2.22 - $3.45 $222 - $345	-100 Reduced 20.0%	400 $0
Q4 2021 Jan 18, 2022	SELL	$2.36 - $3.57 $708 - $1,071	-300 Reduced 37.5%	500 $0
Q3 2021 Oct 26, 2021	SELL	$3.5 - $4.5 $1,400 - $1,800	-400 Reduced 33.33%	800 $0
Q2 2021 Jul 19, 2021	BUY	$3.09 - $4.54 $1,545 - $2,270	500 Added 71.43%	1,200 $0
Q1 2021 Apr 26, 2021	SELL	$3.35 - $4.93 $67,670 - $99,586	-20,200 Reduced 96.65%	700 $1,000
Q4 2020 Jan 21, 2021	BUY	$2.35 - $3.74 $48,645 - $77,418	20,700 Added 10350.0%	20,900 $3,000
Q3 2020 Oct 27, 2020	BUY	$1.78 - $4.13 $356 - $826	200 New	200 $0
Q2 2019 Aug 09, 2019	SELL	$2.02 - $2.61 $15,150 - $19,575	-7,500 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$2.0 - $2.65 $600 - $795	-300 Reduced 3.85%	7,500 $2,000
Q3 2018 Nov 07, 2018	BUY	$2.6 - $3.59 $20,280 - $28,002	7,800 New	7,800 $1,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.84B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.